Regulatory Showdown 16 States Take Legal Action Against Prediction Market Platforms DBS CEO Tan Su Shan Secures Sixth Place in Fortunes 2026 Most Powerful Women List Taiwan Chip Stocks Rally as Nvidia Unveils 150 Billion Spending Plan Mainland Rivals Decline MidAmerica Apartment Communities MAA Faces Lower Rent Growth Outlook After Scotiabank Downgrade Retail Investors Gain Direct Access to SpaceX IPO via Major Brokerage Platforms WHO Declares Ebola Outbreak a Public Health Emergency Potential Economic and Market Implications CR Q1 2026 Earnings EPS Surge Exceeds Expectations Shares Rise FLY Q1 2026 Earnings EPS Beat Fuels Optimism Despite No Revenue Reported CDXS Q1 2026 Earnings Surprise EPS Beat Despite Revenue Uncertainty TIGO Q1 2026 Earnings EPS Misses Estimates by Over 40 Stock Declines Slightly SolarEdge Technologies Inc SEDG Q1 2026 Earnings EPS Misses Estimates by Wide Margin Amid Challenging Solar Market VVV Q1 2026 Earnings EPS Surges 18 Above Estimates Stock Climbs Adicet Bio ACET Edges Higher Modest Gain Amid Key Support and Resistance Levels iShares Staked Ethereum Trust ETHB Declines Slightly as Ethereum Struggles to Hold Gains Nuveen Dynamic Municipal Opportunities Fund NDMO Holds Steady Near 1030 as RangeBound Trading Persists EuroDry Ltd EDRY Pulls Back 214 as Shipping Weakness Persists Civista Bancshares CIVB Slides Amid Sector Pressure Key Support Levels in Focus Joyy JOYY Releases Q4 2025 Earnings Call Transcript PFXNZ Q1 2026 Earnings Earnings Beat Driven by Strong Investment Income and Portfolio Performance Expensify Inc EXFY Holds Steady at 114 as Trading Range Narrows Webster Financial WBS Slips 088 as Stock Tests Key Support Zone National Storage Affiliates Trust NSA Holds Steady Near 43 Amid Modest Gains Quest Diagnostics DGX Edges Higher Key Levels to Watch After Modest Gains ARMOUR Residential REIT Inc ARR Faces Modest Decline as Sector Headwinds Persist Traeger Inc COOK Faces Selling Pressure Testing Key Support Levels Veris Residential VRE Holds Steady Near Support Key Levels in Focus Bolt Biotherapeutics BOLT Gains 36 as Biotech Sector Shows Renewed Interest